Zoellner LA et al., 2017-07: Randomized controlled trial in 42 patients with chronic PTSD comparing imaginal exposure plus 260 mg methylene blue, exposure plus placebo, and waitlist; both exposure arms produced gains that did not differ from standard prolonged exposure, with a responder-level advantage for methylene blue.
MB-augmented exposure specifically enhanced independent evaluator-rated treatment response (number needed to treat = 7.5) and quality of life compared to placebo (effect size d = 0.58).
abstract
Zoellner LA et al., 2017-07: Randomized controlled trial in 42 patients with chronic PTSD comparing imaginal exposure plus 260 mg methylene blue, exposure plus placebo, and waitlist; both exposure arms produced gains that did not differ from standard prolonged exposure, with a responder-level advantage for methylene blue. Study type: randomized trial.
